Results 211 to 220 of about 146,863 (270)
Ethanol inhibits the growth and metastasis of hepatocellular carcinoma by inducing immunogenic cell death. [PDF]
Hsu YC+8 more
europepmc +1 more source
Development of MDM2‐Targeting PROTAC for Advancing Bone Regeneration
This work presents a creative pipeline for developing MDM2‐targeting PROTACs (MDM2‐PROTACs) for application in bone regeneration. The developed PROTACs (CL144 and CL174) are validated for their degradation efficiency and osteogenic effects in human BMSCs.
Sol Jeong+17 more
wiley +1 more source
Successful Treatment of Hyaluronic Acid-Induced Facial Necrosis With Intravenous Dinoprostone. [PDF]
Gaudissart O+3 more
europepmc +1 more source
The study reveals that glutaminolysis in macrophages is inhibited under type 2 diabetes mellitus (T2DM) conditions, which impedes fracture healing by reducing bone morphogenetic protein 2 (BMP2) production through increased cytosine methylation on the promoter.
Jing Wang+12 more
wiley +1 more source
Quantitative evaluation of multiple treatment regimens for treatment-resistant depression. [PDF]
Feng Y+8 more
europepmc +1 more source
IR783‐stabilized nanodrugs composed of NIR dye IR783, ROS inducer β‐lapachone, and epigenetic modulator CUDC101 are designed for breast cancer immunotherapy. The nanodrugs can not only promote cancer cell apoptosis through HDAC inhibition‐enhanced oxidation therapy but also reshape the immunosuppressive microenvironment, which provides a novel strategy
Jinzhao Liu+6 more
wiley +1 more source
Protein nanoparticles as potent delivery vehicles for polycytosine RNA-binding protein one. [PDF]
Zhao ZY, Luo PL, Guo X, Huang ZW.
europepmc +1 more source
This study investigates the integrated diagnostic and therapeutic strategy utilizing 89Zr/131I‐labeled tinurilimab for the management of malignant lung nodules, with a particular focus on lung adenocarcinoma (LUAD). CEACAM6, which is highly expressed in most LUAD patients, activates the Src/FAK signaling pathway, thereby promoting cell proliferation ...
Chongyang Chen+8 more
wiley +1 more source
Editorial: Reviews in pediatric primary immunodeficiencies. [PDF]
Kilic SS.
europepmc +1 more source
Aided by FABP5, abnormally elevated asprosin in hepatocytes enters the nucleus, targets and inhibits PPARα binding to the CPT1A promoter, thereby suppressing FAO. Circulating asprosin exacerbates insulin resistance, collectively driving MASLD progression.
Yuan‐Yuan Yu+13 more
wiley +1 more source